摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-benzoxazol-2-yl-4-nitrophenol | 60344-96-9

中文名称
——
中文别名
——
英文名称
2-benzoxazol-2-yl-4-nitrophenol
英文别名
2-(2-hydroxy-5-nitrophenyl)benzoxazole;2-(2′-hydroxy-5′-nitrophenyl)-1,3-benzoxazole;5'-Nitro-2-(2-hydroxyphenyl)benzoxazol;2-benzooxazol-2-yl-4-nitro-phenol;2-(1,3-Benzoxazol-2-yl)-4-nitrophenol
2-benzoxazol-2-yl-4-nitrophenol化学式
CAS
60344-96-9
化学式
C13H8N2O4
mdl
——
分子量
256.218
InChiKey
UTONFZSGJLALAA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    188 °C(Solv: acetic acid (64-19-7))
  • 沸点:
    427.3±35.0 °C(Predicted)
  • 密度:
    1.463±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    92.1
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-benzoxazol-2-yl-4-nitrophenol溶剂黄146 作用下, 以 为溶剂, 反应 1.5h, 生成 4-氨基-2-苯并噁唑-2-苯酚
    参考文献:
    名称:
    BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS THEREFOR
    摘要:
    公式(I)的化合物:其中R1选择自由基团,包括具有2至12个碳原子的脂肪基,具有3至20个碳原子的芳香基,和具有3至20个碳原子的环脂肪基;但R1不是—C6H5或—NH—C10H7;R2和R3独立选择自由基团,包括羟基,卤原子,具有2至12个碳原子的脂肪基,具有3至20个碳原子的芳香基,和具有3至20个碳原子的环脂肪基;X是氧原子或硫原子;“n”的值为0至4;“m”的值为0至3。
    公开号:
    US20080081913A1
  • 作为产物:
    描述:
    间硝基苯甲酰氯 在 sodium persulfate 、 甲烷磺酸 、 palladium diacetate 作用下, 以 1,4-二氧六环 为溶剂, 反应 21.0h, 生成 2-benzoxazol-2-yl-4-nitrophenol
    参考文献:
    名称:
    Palladium catalyzed Csp2–H activation for direct aryl hydroxylation: the unprecedented role of 1,4-dioxane as a source of hydroxyl radicals
    摘要:
    直接芳香族羟基化已通过使用多功能引导基团通过前所未有的1,4-二氧六环的羟基转移实现钯催化的Csp2-H活化。
    DOI:
    10.1039/c4cc06864e
点击查看最新优质反应信息

文献信息

  • A Magnetic Heterogeneous Biocatalyst Composed of Immobilized Laccase and 2,2,6,6-Tetramethylpiperidine-1-oxyl (TEMPO) for Green One-Pot Cascade Synthesis of 2-Substituted Benzimidazole and Benzoxazole Derivatives under Mild Reaction Conditions
    作者:Mehdi Mogharabi-Manzari、Mahshid Kiani、Sima Aryanejad、Somaye Imanparast、Mohsen Amini、Mohammad Ali Faramarzi
    DOI:10.1002/adsc.201800459
    日期:2018.9.17
    reagent. The prepared catalyst was used to synthesize 12 benzoxazole and benzimidazole derivatives. The onepot, two‐step enzymatic aerobic oxidation reaction included the condensation of in situ‐produced salicylaldehyde derivatives with aromatic amines, followed by an enzymatic dehydrogenation process. Optimal reaction conditions consisted of a citrate buffer (10 mM, pH 4.5) at 40 °C for an incubation
    通过将化学和生化物种固定在磁性纳米颗粒上,可重复使用的高性能多相催化剂的设计可简化,快速且清洁的分离过程,从而提高了催化系统的效率。使用戊二醛作为偶联剂,将漆酶和4-基-2,2,6,6-四甲基哌啶-1-氧基分别固定在胺官能化的氧化铁(II,III)纳米粒子上。所制备的催化剂用于合成12个苯并恶唑苯并咪唑生物。一锅,两步酶促好氧氧化反应包括原位缩合反应。用芳族胺制备水杨醛生物,然后进行酶促脱氢过程。最佳反应条件包括在40°C下柠檬酸缓冲液(10 mM,pH 4.5)孵育10 h和包含固定化漆酶(80 mg,100 U)和固定化2,2,6,6-的非均相催化剂四甲基哌啶-1-氧基(TEMPO)(40 mg,2 mol%)。10次​​运行后,催化剂保留了其初始活性的85%以上。除了可以重复使用而不会对性能造成重大损失外,该催化系统的环保特性还包括其高催化活性和使用外部磁体从反应混合物中回收的便捷性。
  • Half-sandwich chromium(III) complexes containing salicylbenzoxazole and salicylbenzothiazole ligands for ethylene polymerization
    作者:Hui Liu、Suting Xu、Xiaochao Shi
    DOI:10.1016/j.inoche.2021.108885
    日期:2021.11
    Half-sandwich chromium(III) complexes bearing salicylbenzoxazole ligands 2a-2f [L = R-2-(benzo[d]xazol-2-yl)-phenol (R = H (2a), R = 6-CH3 (2b), R = 6-tBu (2c), R = 4-OCH3 (2d), R = 4-Cl (2e), R = 4-NO2 (2f)] and salicylbenzothiazole ligands 3a-3f [L = R-2-(benzo[d]xazol-2-yl)-phenol (R = H (3a), R = 6-CH3 (3b), R = 6-tBu (3c), R = 4-OCH3 (3d), R = 4-Cl (3e), R = 4-NO2 (3f)] were synthesized by the
    带有杨基苯并恶唑配体2a - 2f [L = R-2-(苯并[d]恶唑-2-基)-苯酚 (R = H ( 2a ), R = 6-CH 3 ( 2b) ), R = 6- t Bu ( 2c ), R = 4-OCH 3 ( 2d ), R = 4-Cl ( 2e ), R = 4-NO 2 ( 2f )] 和杨基苯并噻唑配体3a - 3f [L = R-2-(benzo[d]xazol-2-yl)-phenol (R = H ( 3a ), R = 6-CH 3 ( 3b ), R = 6- t Bu ( 3c ), R = 4-OCH 3( 3d ), R = 4-Cl ( 3e ), R = 4-NO 2 ( 3f )]是通过CpCrCl 2 (THF)和相应配体的钠盐在-78℃下在THF中的脱盐反应合成的℃。配合物3a和3e的分子结构由单晶 X 射线晶体学分析证实。在少量AlEt
  • AUTHENTICATABLE ARTICLES AND METHODS THEREFOR
    申请人:Chauhan Yogendrasinh Bharatsinh
    公开号:US20080081210A1
    公开(公告)日:2008-04-03
    An article comprising the compound of Formula (I): wherein R 1 is selected from the group consisting of an aliphatic functionality having 1 to 12 carbons, an aromatic functionality having 3 to 20 carbons, and a cycloaliphatic functionality having 3 to 20 carbons; R 2 and R 3 are independently selected from the group consisting of a hydroxyl group, a halogen atom, an aliphatic functionality having 1 to 12 carbons, an aromatic functionality having 3 to 20 carbons, and a cycloaliphatic functionality having 3 to 20 carbons; Y is either an oxygen atom or a sulfur atom; “n” has a value of 0 to 4; and “m” has a value of 0 to 3.
    本文涉及一种化合物,其化学式为(I):其中R1选自具有1到12个碳的脂肪基、具有3到20个碳的芳香基和具有3到20个碳的环烷基的群组之一;R2和R3独立地选自具有1到12个碳的脂肪基、具有3到20个碳的芳香基和具有3到20个碳的环烷基的群组之一,以及羟基、卤素原子;Y是氧原子或原子;“n”的值为0到4;“m”的值为0到3。
  • Somayajulu; Rao, Current Science, 1956, vol. 25, p. 86
    作者:Somayajulu、Rao
    DOI:——
    日期:——
  • In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors
    作者:Sulaksha Desai、Vidya Desai、Sunil Shingade
    DOI:10.1016/j.bioorg.2019.103382
    日期:2020.1
    A series of benzoxazole-N-heterocyclic hybrids have been synthesized by a one-pot strategy. Molecular docking study revealed that such compounds have the ability to inhibit enzyme protein tyrosine kinase. The findings of this work have been the successful synthesis of benzoxazole scaffolds, featuring hybrids of benzoxazole with quinoline and quinoxaline respectively. The molecular docking studies have showed these compounds to be inhibitors of tyrosine kinase enzyme which triggers growth of cancer cells. The cytotoxicity study of compounds 4a-f showed better potency against breast cancer cell lines MCF-7 and MDA-MB-231 in contrast to oral and lung cancer cell lines KB and A549. The tyrosine kinase activity was measured using Universal Tyrosine Kinase Assay kit using horseradish peroxide (HRP)-conjugated anti-phosphotyrosine kinase solution as a substrate. The compounds 4c exhibited maximum inhibition in the activity of enzyme tyrosine kinase with IC50 value 0.10 +/- 0.16 mu M, than other compounds which were studied and thus proved to be inhibitors of enzyme tyrosine kinase. The selective index of all four compounds was found out to be greater than two, indicating the non-toxic behaviour, i.e. good anti-cancer activity. Further, fluorescence microscopic study helped to characterize the mode of cell death, which was found to be late apoptosis as indicated by the orange fluorescence. The SAR analysis has also been carried out.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)